FT-023(Frontera Therapeutics (Shanghai) Co Ltd)

N/A

Report date: 2026/01/05 13:58:19

Base Information

Drug NameFT-023(Frontera Therapeutics (Shanghai) Co Ltd)
Drug Alias NameFT-023FT023
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFrontera Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFrontera Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A